110 likes | 120 Views
This qualitative, systematic review explores the possible influences of pharmaceutical companies on the findings, protocols, and quality of drug trials. It discusses the impact of financing on the integrity and reliability of research.
E N D
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279